EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancer

• Shawn J. Rice,

  Roles Conceptualization, Data curation, Formal analysis, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Penn State Hershey Cancer Institute, Hershey, Pennsylvania, United States of America

  ⨯
• Xin Liu,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Supervision, Writing – review & editing

  Affiliation Penn State Hershey Cancer Institute, Hershey, Pennsylvania, United States of America

  ⨯
• Hong-Gang Wang,

  Roles Conceptualization, Investigation, Methodology, Resources, Supervision, Writing – review & editing

  Affiliations Penn State Hershey Cancer Institute, Hershey, Pennsylvania, United States of America, Department of Pediatrics, Penn State College of Medicine, Hershey, Pennsylvania, United States of America

  ⨯
• Chandra P. Belani

  Roles Conceptualization, Formal analysis, Resources, Supervision, Writing – review & editing

  * E-mail: cbelani@psu.edu

  Affiliations Penn State Hershey Cancer Institute, Hershey, Pennsylvania, United States of America, Department of Medicine, Penn State College of Medicine, Hershey, Pennsylvania, United States of America

  http://orcid.org/0000-0001-5049-5329

  ⨯